BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 21, 2003
View Archived Issues
Chiron Plans To Pay £542 Million In Cash To Acquire PowderJect
LONDON - Chiron Corp. plans to acquire PowderJect Pharmaceuticals plc in an agreed-to cash offer valuing the vaccines manufacturer at £542 million (US$878 million). (BioWorld International)
Read More
EU Officials Call U.S. Complaint On GMOs 'Misguided, Unhelpful'
Read More
HIV's Vif Protein Revealed As Potential Therapeutic Target
Read More
Germany At Forefront Of Effort For International Cloning Ban
Read More
CAT Cuts Staff As Part Of Plan To Concentrate On Development
Read More
Seven Organizations Launch Alternative Splicing Project
Read More
MedPharma Postpones IPO As Markets Remain Resistant
Read More
Transgene Pushing Ahead With Targeted Development Program
Read More
Other News To Note
Read More